BRPI1011413B1 - Sistema, método e marcador luminescente para geração de imagem luminescente difusa melhorada ou tomografia em meio de dispersão - Google Patents
Sistema, método e marcador luminescente para geração de imagem luminescente difusa melhorada ou tomografia em meio de dispersão Download PDFInfo
- Publication number
- BRPI1011413B1 BRPI1011413B1 BRPI1011413-0A BRPI1011413A BRPI1011413B1 BR PI1011413 B1 BRPI1011413 B1 BR PI1011413B1 BR PI1011413 A BRPI1011413 A BR PI1011413A BR PI1011413 B1 BRPI1011413 B1 BR PI1011413B1
- Authority
- BR
- Brazil
- Prior art keywords
- excitation
- marker
- luminescent
- light source
- light
- Prior art date
Links
- 239000003550 marker Substances 0.000 title claims abstract description 76
- 238000000034 method Methods 0.000 title claims abstract description 67
- 238000003325 tomography Methods 0.000 title claims abstract description 47
- 239000006185 dispersion Substances 0.000 title description 4
- 230000005284 excitation Effects 0.000 claims abstract description 123
- 238000004020 luminiscence type Methods 0.000 claims abstract description 61
- 238000003384 imaging method Methods 0.000 claims abstract description 49
- 238000005286 illumination Methods 0.000 claims abstract description 6
- 238000001514 detection method Methods 0.000 claims description 9
- 238000004364 calculation method Methods 0.000 claims description 8
- 230000009467 reduction Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 8
- 210000001519 tissue Anatomy 0.000 description 41
- 239000002105 nanoparticle Substances 0.000 description 35
- 238000006243 chemical reaction Methods 0.000 description 23
- 230000008569 process Effects 0.000 description 21
- 238000009826 distribution Methods 0.000 description 19
- 230000003287 optical effect Effects 0.000 description 19
- 230000009102 absorption Effects 0.000 description 18
- 238000010521 absorption reaction Methods 0.000 description 18
- 239000002159 nanocrystal Substances 0.000 description 17
- 238000000799 fluorescence microscopy Methods 0.000 description 16
- 239000000523 sample Substances 0.000 description 15
- 239000002609 medium Substances 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 10
- 230000001419 dependent effect Effects 0.000 description 9
- 239000002096 quantum dot Substances 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 239000002872 contrast media Substances 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 8
- 238000002073 fluorescence micrograph Methods 0.000 description 8
- 239000007850 fluorescent dye Substances 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 8
- 238000002595 magnetic resonance imaging Methods 0.000 description 8
- 238000005424 photoluminescence Methods 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 230000007704 transition Effects 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 239000000090 biomarker Substances 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 230000005281 excited state Effects 0.000 description 7
- 108091006047 fluorescent proteins Proteins 0.000 description 7
- 102000034287 fluorescent proteins Human genes 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 230000003902 lesion Effects 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000002612 dispersion medium Substances 0.000 description 6
- 238000002189 fluorescence spectrum Methods 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000004088 simulation Methods 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 4
- -1 aromatic amino acids Chemical class 0.000 description 4
- 230000001427 coherent effect Effects 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000007306 functionalization reaction Methods 0.000 description 4
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 4
- 229960004657 indocyanine green Drugs 0.000 description 4
- 229910052761 rare earth metal Inorganic materials 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 229960003569 hematoporphyrin Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000003504 photosensitizing agent Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910052688 Gadolinium Inorganic materials 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000012984 biological imaging Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000009543 diffuse optical tomography Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000012632 fluorescent imaging Methods 0.000 description 2
- 150000004673 fluoride salts Chemical class 0.000 description 2
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 2
- 150000002251 gadolinium compounds Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000005283 ground state Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000005291 magnetic effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004154 testing of material Methods 0.000 description 2
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 2
- 208000007204 Brain death Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 229910052691 Erbium Inorganic materials 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 238000000342 Monte Carlo simulation Methods 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006854 communication Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000012899 de-mixing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940028435 intralipid Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229910000311 lanthanide oxide Inorganic materials 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- HQHVZNOWXQGXIX-UHFFFAOYSA-J sodium;yttrium(3+);tetrafluoride Chemical compound [F-].[F-].[F-].[F-].[Na+].[Y+3] HQHVZNOWXQGXIX-UHFFFAOYSA-J 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000004613 tight binding model Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229910003366 β-NaYF4 Inorganic materials 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0068—Confocal scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0073—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by tomography, i.e. reconstruction of 3D images from 2D projections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- High Energy & Nuclear Physics (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Endoscopes (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0950313-7 | 2009-05-05 | ||
| SE0950313 | 2009-05-05 | ||
| US21588109P | 2009-05-12 | 2009-05-12 | |
| US61/215,881 | 2009-05-12 | ||
| US25513909P | 2009-10-27 | 2009-10-27 | |
| US61/255,139 | 2009-10-27 | ||
| PCT/EP2010/056127 WO2010128090A1 (en) | 2009-05-05 | 2010-05-05 | A system, method, and luminescent marker for improved diffuse luminescent imaging or tomography in scattering media |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1011413A2 BRPI1011413A2 (pt) | 2016-03-15 |
| BRPI1011413B1 true BRPI1011413B1 (pt) | 2021-09-14 |
Family
ID=42312993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1011413-0A BRPI1011413B1 (pt) | 2009-05-05 | 2010-05-05 | Sistema, método e marcador luminescente para geração de imagem luminescente difusa melhorada ou tomografia em meio de dispersão |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9012869B2 (enExample) |
| EP (1) | EP2427100B1 (enExample) |
| JP (3) | JP2012525883A (enExample) |
| KR (1) | KR20120036304A (enExample) |
| CN (1) | CN102497803B (enExample) |
| AU (1) | AU2010244431B2 (enExample) |
| BR (1) | BRPI1011413B1 (enExample) |
| CA (1) | CA2760783C (enExample) |
| IL (1) | IL216125A (enExample) |
| SG (1) | SG175923A1 (enExample) |
| WO (1) | WO2010128090A1 (enExample) |
| ZA (1) | ZA201108562B (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2810822C (en) * | 2009-09-22 | 2018-03-06 | Visen Medical, Inc. | Systems and methods for virtual index-matching of diffusive media |
| JP6087049B2 (ja) * | 2011-11-02 | 2017-03-01 | 浜松ホトニクス株式会社 | 蛍光ファントム装置および蛍光イメージング方法 |
| CA2879769C (en) * | 2012-07-01 | 2022-06-21 | Lumito Ab | A system and method for improved diffuse luminescent imaging or tomography in scattering media |
| CN103207168A (zh) * | 2012-12-26 | 2013-07-17 | 西安交通大学 | 一种心肌细胞膜电位功能信息光学重构方法 |
| CN104674994A (zh) * | 2015-01-09 | 2015-06-03 | 湘潭市众成宏鑫建筑材料有限公司 | 一种用于现浇空心楼盖的组合芯模及其制作方法 |
| US10379046B2 (en) * | 2015-04-08 | 2019-08-13 | Molecular Devices, Llc | Method and system for multiplexed time-resolved fluorescence detection |
| US11971354B2 (en) | 2015-04-08 | 2024-04-30 | Molecular Devices, Llc | Methods and systems for fluorescence detection using infrared dyes |
| WO2017147528A1 (en) * | 2016-02-26 | 2017-08-31 | University Of Southern California | Optimized volumetric imaging with selective volume illumination and light field detection |
| US9730649B1 (en) | 2016-09-13 | 2017-08-15 | Open Water Internet Inc. | Optical imaging of diffuse medium |
| DE102016124730A1 (de) * | 2016-12-16 | 2018-06-21 | Olympus Winter & Ibe Gmbh | Endoskopiesystem und Lichtquelle eines Endoskopiesystems |
| US12019074B2 (en) | 2017-06-08 | 2024-06-25 | Lumito Ab | Method of analysing a sample for at least one analyte |
| KR101998582B1 (ko) | 2017-12-28 | 2019-07-10 | 주식회사 에스에프에이 | 멀티 트레이 무인 반송대차 시스템 |
| US10506181B2 (en) | 2018-03-31 | 2019-12-10 | Open Water Internet Inc. | Device for optical imaging |
| US10778912B2 (en) | 2018-03-31 | 2020-09-15 | Open Water Internet Inc. | System and device for optical transformation |
| US10778911B2 (en) | 2018-03-31 | 2020-09-15 | Open Water Internet Inc. | Optical transformation device for imaging |
| US10966612B2 (en) | 2018-06-14 | 2021-04-06 | Open Water Internet Inc. | Expanding beam optical element |
| US10962929B2 (en) | 2018-09-14 | 2021-03-30 | Open Water Internet Inc. | Interference optics for optical imaging device |
| US10874370B2 (en) | 2019-01-28 | 2020-12-29 | Open Water Internet Inc. | Pulse measurement in optical imaging |
| US10955406B2 (en) | 2019-02-05 | 2021-03-23 | Open Water Internet Inc. | Diffuse optical imaging with multiple beams |
| IL265914B (en) * | 2019-04-08 | 2020-11-30 | Convergent R N R Ltd | System and method for optimization of radiotherapy treatments |
| US11320370B2 (en) | 2019-06-26 | 2022-05-03 | Open Water Internet Inc. | Apparatus for directing optical and acoustic signals |
| US11581696B2 (en) | 2019-08-14 | 2023-02-14 | Open Water Internet Inc. | Multi-channel laser |
| US11622686B2 (en) | 2019-11-22 | 2023-04-11 | Open Water Internet, Inc. | Optical imaging with unshifted reference beam |
| US11819318B2 (en) | 2020-04-27 | 2023-11-21 | Open Water Internet Inc. | Optical imaging from light coherence |
| US11259706B2 (en) | 2020-05-19 | 2022-03-01 | Open Water Internet Inc. | Dual wavelength imaging and out of sample optical imaging |
| US11559208B2 (en) | 2020-05-19 | 2023-01-24 | Open Water Internet Inc. | Imaging with scattering layer |
| KR102646948B1 (ko) * | 2021-06-07 | 2024-03-13 | 전남대학교산학협력단 | 유전자 조작 박테리아를 이용한 소장 내 급성 저산소성 허혈성 조직 진단에 필요한 정보를 제공하는 방법 |
| EP4439133A1 (en) | 2023-03-27 | 2024-10-02 | Lumito AB | A microscope for upconverting nanoparticles |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5451785A (en) * | 1994-03-18 | 1995-09-19 | Sri International | Upconverting and time-gated two-dimensional infrared transillumination imaging |
| US5832931A (en) * | 1996-10-30 | 1998-11-10 | Photogen, Inc. | Method for improved selectivity in photo-activation and detection of molecular diagnostic agents |
| US20010032053A1 (en) * | 2000-01-24 | 2001-10-18 | Hielscher Andreas H. | Imaging of a scattering medium using the equation of radiative transfer |
| EP1207387A1 (en) * | 2000-11-20 | 2002-05-22 | Institut Curie | Multi-photon imaging installation. |
| US6615063B1 (en) * | 2000-11-27 | 2003-09-02 | The General Hospital Corporation | Fluorescence-mediated molecular tomography |
| US6687620B1 (en) * | 2001-08-01 | 2004-02-03 | Sandia Corporation | Augmented classical least squares multivariate spectral analysis |
| JP4804665B2 (ja) * | 2001-08-09 | 2011-11-02 | オリンパス株式会社 | レーザ顕微鏡 |
| CA2458802C (en) * | 2001-09-06 | 2016-06-07 | Genomic Profiling Systems, Inc. | Rapid and sensitive detection of molecules |
| JP2003344285A (ja) * | 2002-05-24 | 2003-12-03 | Japan Science & Technology Corp | 環状断面レーザ光ビーム生成器および多光子顕微鏡 |
| US7303741B2 (en) | 2002-09-23 | 2007-12-04 | General Electric Company | Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism |
| DE10255013B4 (de) | 2002-11-25 | 2004-12-09 | Siemens Ag | Verfahren und Vorrichtung zur Lokalisierung von Licht emittierenden Bereichen |
| EP1594551A2 (en) * | 2003-02-19 | 2005-11-16 | Sicel Technologies, Inc. | In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
| JP2007528500A (ja) | 2004-03-11 | 2007-10-11 | ザ・ゼネラル・ホスピタル・コーポレーション | 蛍光タンパク質を使用する断層撮影イメージングのための方法およびシステム |
| JP4309787B2 (ja) * | 2004-03-12 | 2009-08-05 | オリンパス株式会社 | 多光子励起型測定装置 |
| US7302348B2 (en) * | 2004-06-02 | 2007-11-27 | Agilent Technologies, Inc. | Method and system for quantifying and removing spatial-intensity trends in microarray data |
| JP2006023382A (ja) * | 2004-07-06 | 2006-01-26 | Olympus Corp | 光走査型観察装置 |
| JP4471162B2 (ja) * | 2004-07-14 | 2010-06-02 | 富士フイルム株式会社 | 蛍光ｃｔ装置 |
| JP2008534508A (ja) * | 2005-03-22 | 2008-08-28 | メドスター ヘルス インコーポレイテッド | 心血管疾患を診断および処置するための送達システムおよび方法 |
| ATE441103T1 (de) * | 2005-07-22 | 2009-09-15 | Zeiss Carl Microimaging Gmbh | Auflísungsgesteigerte lumineszenz-mikroskopie |
| US20080269617A1 (en) * | 2005-11-10 | 2008-10-30 | Koninklijke Philips Electronics, N.V. | Absorption and Scattering Map Reconstruction For Optical Fluorescence Tomography |
| WO2007078262A1 (en) | 2006-01-06 | 2007-07-12 | National University Of Singapore | Method of preparing nano-structured material(s) and uses thereof |
| WO2007109678A2 (en) * | 2006-03-20 | 2007-09-27 | Baylor College Of Medicine | Method and system for non-contact fluorescence optical tomography with patterned illumination |
| FR2900043B1 (fr) * | 2006-04-24 | 2008-07-04 | Commissariat Energie Atomique | Procede d'imagerie optique par fluorescence de tissus biologiques, notamment pour delimiter des regions d'interet des tissus a analyser par tomographie |
| WO2008048190A1 (en) | 2006-10-17 | 2008-04-24 | National University Of Singapore | Upconversion fluorescent nano-structured material and uses thereof |
| GB0707433D0 (en) * | 2007-04-18 | 2007-05-23 | Stfc Science & Technology | Fluorescence measurement |
| US8389958B2 (en) * | 2009-03-18 | 2013-03-05 | Duke University | Up and down conversion systems for production of emitted light from various energy sources |
| WO2009046392A1 (en) | 2007-10-04 | 2009-04-09 | Trustees Of Princeton University | Synthesis of bio-functionalized rare earth doped upconverting nanophosphors |
-
2010
- 2010-05-05 CN CN201080030265.6A patent/CN102497803B/zh active Active
- 2010-05-05 KR KR1020117028821A patent/KR20120036304A/ko not_active Abandoned
- 2010-05-05 WO PCT/EP2010/056127 patent/WO2010128090A1/en not_active Ceased
- 2010-05-05 SG SG2011081874A patent/SG175923A1/en unknown
- 2010-05-05 US US13/318,403 patent/US9012869B2/en active Active
- 2010-05-05 BR BRPI1011413-0A patent/BRPI1011413B1/pt active IP Right Grant
- 2010-05-05 CA CA2760783A patent/CA2760783C/en active Active
- 2010-05-05 JP JP2012509034A patent/JP2012525883A/ja active Pending
- 2010-05-05 EP EP10720382.0A patent/EP2427100B1/en active Active
- 2010-05-05 AU AU2010244431A patent/AU2010244431B2/en not_active Ceased
-
2011
- 2011-11-03 IL IL216125A patent/IL216125A/en active IP Right Grant
- 2011-11-22 ZA ZA2011/08562A patent/ZA201108562B/en unknown
-
2016
- 2016-04-20 JP JP2016084227A patent/JP6650334B2/ja not_active Expired - Fee Related
-
2018
- 2018-05-22 JP JP2018097799A patent/JP2018128470A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL216125A (en) | 2014-11-30 |
| CN102497803A (zh) | 2012-06-13 |
| EP2427100B1 (en) | 2021-08-11 |
| CA2760783A1 (en) | 2010-11-11 |
| US20120104281A1 (en) | 2012-05-03 |
| JP2018128470A (ja) | 2018-08-16 |
| BRPI1011413A2 (pt) | 2016-03-15 |
| AU2010244431B2 (en) | 2015-05-14 |
| JP2016135316A (ja) | 2016-07-28 |
| WO2010128090A1 (en) | 2010-11-11 |
| CN102497803B (zh) | 2015-03-25 |
| JP6650334B2 (ja) | 2020-02-19 |
| EP2427100A1 (en) | 2012-03-14 |
| JP2012525883A (ja) | 2012-10-25 |
| IL216125A0 (en) | 2012-01-31 |
| ZA201108562B (en) | 2015-05-27 |
| US9012869B2 (en) | 2015-04-21 |
| AU2010244431A1 (en) | 2011-12-01 |
| SG175923A1 (en) | 2011-12-29 |
| KR20120036304A (ko) | 2012-04-17 |
| CA2760783C (en) | 2018-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9012869B2 (en) | System, method, and luminescent marker for improved diffuse luminescent imaging or tomography in scattering media | |
| Ntziachristos et al. | Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging | |
| CN104603600B (zh) | 用于散射介质中改进的扩散发光成像或者断层照相的系统和方法 | |
| Graves et al. | Fluorescence molecular imaging of small animal tumor models | |
| Kumar et al. | A time domain fluorescence tomography system for small animal imaging | |
| Stuker et al. | Fluorescence molecular tomography: principles and potential for pharmaceutical research | |
| Zacharakis et al. | Fluorescent protein tomography scanner for small animal imaging | |
| CA2877437A1 (en) | Method and arrangement for the relative position detection of stations by means of radio location | |
| JP2001503748A (ja) | 分子薬の光活性における選択性改善と検出のための方法 | |
| US7809431B2 (en) | Method of optically imaging biological tissues by using fluorescence, in particular for defining regions of interest in tissues to be analyzed by tomography | |
| Eruv et al. | An alternative approach to analyze fluorescence lifetime images as a base for a tumor early diagnosis system | |
| Zacharakis et al. | Three-dimensional optical tomography of fluorescent proteins in the visible | |
| Da Silva et al. | In vivo fluorescence molecular optical imaging: from small animal towards clinical applications | |
| Balalaeva et al. | Diffuse fluorescence tomography of exo-and endogenously labeled tumors | |
| Ducros et al. | A simulation-based study of reconstruction in Time-resolved Fluorescence Diffuse Optical Tomography in Cylindrical geometry | |
| Sevick-muraca | Fluorescence Lifetime Imaging for Breast Cancer Detection and Diagnosis | |
| Davis et al. | MRI-coupled fluorescence tomography of murine glioma metabolic activity | |
| Tan | Quantitative fluorescence molecular tomography: Algorithms, simulations, and phantom/in vivo experiments | |
| Svensson et al. | Upconverting luminescence imaging and tomography for biomedical applications | |
| Ale et al. | Optical Imaging | |
| Terike et al. | Fluorescence Spectroscopy Utilized to Determine the Depth of an Embedded inclusion in Molecular Imaging | |
| Svenmarker | Optical spectroscopy and fluorescence imaging for cancer diagnostics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/05/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |